RU-486 (Mifepristone) ameliorates diabetes but does not correct deficient β-adrenergic signalling in adipocytes from mature C57BL/6J-ob/ob mice

International Journal of Obesity

Volumn 21, Issue 10, 1997, Pages 865-873

  Gettys, T W ^a,c   Watson, P M ^a   Taylor, I L ^a   Collins, S ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adenylylcyclase; G proteins; Obesity; Receptor signalling

Indexed keywords

ADENYLATE CYCLASE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; GLUCOCORTICOID ANTAGONIST; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; ISOPRENALINE; MESSENGER RNA; MIFEPRISTONE; RECEPTOR SUBTYPE;

ADIPOCYTE; ADIPOCYTE MEMBRANE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HYPERADRENOCORTICISM; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYMPTOM;

ANIMALIA;

EID: 0030772085     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800479     Document Type: Article

References (50)

1. Dubuc PU. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice. Metabolism 1976; 25: 1567-1574.
2. Dehaye JP, Winand J, Christophe J. Lipolysis and cyclic AMP levels in epididymal adipose tissue of obese-hyperglycaemic mice. Diabetologia 1977; 13: 553-561.
3. Begin-Heick N, Heick HM. Increased response of adipose tissue of the ob/ob mouse to the action of adrenaline after treatment with thyroxin. Can J Physiol Pharmacol 1977; 55: 1320-1329.
4. Marshall NB, Engel FL. The influence of epinephrine and fasting on adipose tissue content and release of free fatty acids in obese-hyperglycemic and lean mice. J Lipid Res 1960; 1: 339-342.
5. Gettys TW, Ramkumar V, Uhing RJ, Seger L, Taylor IL. Alterations in mRNA levels, expression, and function of GTP-binding regulatory proteins in adipocytes from obese mice (C57BL/6J-ob/ob). J Biol Chem 1991; 266: 15949-15955.
6. Collins S, Daniel KW, Rohlfs EM, Ramkumar V, Taylor IL, Gettys TW. Impaired expression and functional activity of the β-3 and β-1 adrenergic receptor in adipose tissue of congenitally obese (C57BLJ6-ob/ob) mice. Mol Endocrinol 1994; 8: 518-527.
7. Feve B, Baude B, Krief S, Strosberg AD, Pairault J, Emorine LJ. Inhibition by dexamethasone of β3-adrenergic receptor responsiveness in 3T3-F442A adipocytes. Evidence for a transcriptional mechanism. J Biol Chem 1992; 267: 15909-15915.
8. Malbon CC, Graziano MP, Johnson GL. Fat cell β adrenergic receptors in the hypothyroid rat. J Biol Chem 1984; 259: 3254-3260.
9. Tokuyama K, Himms-Hagen J. Increased sensitivity of the genetically obese mouse to corticosterone. Am J Physiol 1987; 252: E202-E208.
10. Tokuyama K, Himms-Hagen J. Enhanced acute response to corticosterone in genetically obese (ob/ob) mice. Am J Physiol 1989; 257: E133-E138.
11. Walker HC, Romsos DR. Glucocorticoids in the CNS regulate BAT metabolism and plasma insulin in ob/ob mice. Am J Physiol 1992; 262: E110-E117.
12. Dubuc PU, Peterson CM. Ineffectiveness of parenteral fluoxetine or RU-486 to alter long-term food intake, body weight or body composition of genetically obese mice. J Pharmacol Exp Ther 1990; 255: 976-979.
13. Hardwick AJ, Linton EA, Rothwell NJ. Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of corticortropin-releasing factor and sympathetic activation of brown adipose tissue. Endocrinology 1989; 124: 1684-1688.
14. Langley SC, York DA. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats. Am J Physiol 1990; 259: R539-R544
15. Okada S, York DA, Bray GA. Mifepristone (RU 486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity. Am J Physiol Regul Integr Comp Physiol 1992; 262: R1106-R1110.
16. Gettys TW, Garcia R, Savage K, Whitcomb DC, Kanayama S, Taylor IL. Insulin sparing effects of pancreatic polypeptide in congenitally obese rodents. Pancreas 1991; 6: 45-53.
17. Rodbell M, Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964; 239: 375-380.
18. Gettys TW, Blackmore PF, Redmon JB, Beebe SJ, Corbin JD Short-term feedback regulation of cAMP by accelerated degradation in rat tissues. J Biol Chem 1987; 262: 333-339.
19. Morre DJ, Morre DM. Preparation of mammalian plasma membranes by aqueous two-phase partition. Biotechniques 1989; 7: 946-958.
20. Goldsmith P, Gierschik P, Milligan G, Unson CG, Vinitsky R, Malech HL, Spiegel AM. Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain. J Biol Chem 1987; 262: 14683-14688.
21. Goldsmith P, Rossiter K, Carter A, Simonds W, Unson CG, Vinitsky R, Spiegel AM. Identification of the GTP-binding protein encoded by Gi3 complementary DNA. J Biol Chem 1988; 263: 6476-6479.
22. Gettys TW, Sheriff-Carter K, Moomaw J, Taylor IL, Raymond JR. Characterization and use of crude alpha-subunit preparations for quantitative immunoblotting of G proteins. Anal Biochem 1994; 220: 82-91.
23. Linder ME, Gilman AG. Purification of recombinant Gi-alpha and Go-alpha proteins from Escherichia coli. Methods Enzymol 1991; 195: 202-215.
24. Uhing RJ, Polakis PG, Snyderman R. Isolation of GTP-binding proteins from myeloid HL-60 cells. J Biol Chem 1987; 262: 15575-15579.
25. Mumby S, Pang I-K, Gilman AG, Sternweiss PC. Chromatographic resolution and immunologie identification of the alpha-40 and alpha-41 subunits of guanine nucleotide-binding regulatory proteins. J Biol Chem 1988; 263: 2020-2026.
26. Gettys TW, Rohlfs EM, Prpic V, Daniel KW, Taylor IL, Collins S. Age-dependent changes in β-adrenergic receptor subtypes and adenylyl cyclase activation in adipocytes from Fischer 344 rats. Endocrinology 1995; 136: 2022-2032.
27. Gettys TW, Okonogi K, Tarry WC, Johnston J, Horton C, Taylor IL. Examination of relative rates of cAMP synthesis and degradation in crude membranes of adipocytes treated with hormones. Second Messengers and Phosphoproteins 1990; 13: 37-50.
28. 3 receptors. A promising antidiabetic and antiobesity agent. J Med Chem 1992; 35: 3081-3084.
29. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 1984; 309: 163-165.
30. Gettys TW, Fields TA, Raymond JR. Selective activation of inhibitory G protein alpha-subunits by partial agonists of the human 5-HRT1A receptor. Biochemistry 1994; 33: 4283-4290.
31. Dubuc PU, Wilden NJ. Adrenalectomy reduces but does not reverse obesity in ob/ob mice. Int J Obesity 1986; 10: 91-98.
32. Saito M, Bray GA. Adrenalectomy and food restriction in the genetically obese (ob/ob) mouse. Am J Physiol 1984; 248: E20-E25.
33. Bray GA. Pathophysiology of obesity. Am J Clin Nutr 1992; 55 Suppl.: 488S-494S.
34. Bray GA, York DA. Genetically transmitted obesity in rodents. Physiol Rev 1979; 51: 598-646.
35. Turnbow MA, Keller SR, Rice KM, Garner CW. Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3-L1 adipocytes. J Biol. Chem 1994; 269: 2516-2520.
36. Kahn CR. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43: 1066-1084.
37. Chen NG, Romsos DR. Enhanced sensitivity of pancreatic islets from preobese 2-week-old ob/ob mice to neurohormonal stimulation of insulin secretion. Endocrinology 1995; 136: 505-511.
38. Tassava TM, Okuda T, Romsos DR. Insulin secretion from ob/ob mouse pancreatic islets: Effects of neurotransmitters. Am J Physiol Endocrinol Metab 1992; 262: E338-E343.
39. Stubbs M, York DA. Central glucocorticoid regulation of parasympathetic drive to pancreatic B-cells in the obese fa/fa rat. Int J Obesity 1991; 15: 547-553.
40. Giacchetti G, Faloia E, Taccaliti A, Morosini PP, Arnaldi G, Soletti F, Mantero F, Accili D, De Pirro R. Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: Evaluation by a simplified quantitative PCR assay. J Endocrinol Invest 1994; 17: 709-715.
41. Kahn BB. Alterations in glucose transporter expression and function in diabetes: Mechanisms for insulin resistance. J Cell Biochem 1992; 48: 122-128.
42. Kahn BB, Pedersen O. Tissue-specific regulation of glucose transporters in different forms of obesity. Proc Soc Exp Biol Med 1992; 200: 214-217.
43. Pedersen O, Kahn CR, Kahn BB. Divergent regulation of the Glut 1 and Glut 4 glucose transporters in isolated adipocytes from Zucker rats. J Clin Invest 1992; 89: 1964-1973.
44. MacDougal OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995; 64: 345-373.
45. Stiles GL, Caron MG, Lefkowitz RJ. β-Adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev 1984; 64: 661-761.
46. Collins S, Caron MG, Lefkowitz RJ. Beta-2 adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 1988; 263: 9067-9070.
47. 2-adrenergic receptor protein and mRNA levels by glucocorticoids during 3T3-F442A adipose differentiation. J Biol Chem 1990; 265: 16343-16349.
48. 3-adrenergic receptor expression in 3T3-F442A adipocytes: A mechanism for repressing the cAMP signalling pathway. Proc Natl Acad Sci USA 1994; 91: 5677-5681.
49. 2-adrenergic receptors in rat adipose tissue in altered thyroid states. Biochem J 1996; 322: 145-150.
50. Collins S, Quarmby VE, French F, Lefkowitz RJ, Caron MG. Regulation of the Beta-2 adrenergic receptor in the rat ventral prostate by testosterone. FEBS Lett 1988; 233: 173-176.